EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial

Muhammad N Aslam iD, Danielle Kim Turgeon, Henry D Appelman, Ryan Stidham, Shannon McClintock, Ron Allen, Gillian Moraga, Isabelle Harber iD, Kara J Jencks, Molly M McNeely, Ananda Sen, Karl J Jepsen und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0337408 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Muhammad N Aslam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Minerals. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, American Society for Investigative Pathology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The long-term goal of our ongoing studies is to determine if, and to what extent, a multi-mineral product (Aquamin) could benefit individuals with ulcerative colitis (UC). As a step toward achieving that goal, we carried out a pilot 180-day biomarker trial (clinicaltrials.gov ID: NCT03869905) in patients with UC in remission or with mild disease. Approach A total of 28 subjects participated in the study. Each subject was randomly assigned to receive either Aquamin for 180 days or placebo for 90 days. At Day-90, placebo subjects crossed over to Aquamin for the final 90 days. At Day-0, -90 and -180, serum samples were analyzed for C-reactive protein (CRP), alkaline phosphatase (ALP), intestine-specific ALP (ALPI), and for biomarkers of bone turnover (osteocalcin, TRAP5b and bone-specific ALP [BALP]). Stool specimens were assessed for fecal calprotectin (fCAL) and colon biopsies were examined histologically by Geboes scoring at the same time points. Each subject underwent DEXA scanning (at Day-0 and Day-180 only). In addition, mass spectrometry-based proteomic assessment was performed using colon biopsies obtained at each time point.

Results

Subjects who received Aquamin for the complete 180-day period (a total of 12) demonstrated improvements in all biomarkers (CRP, fCAL, ALP, ALPI, and Geboes scoring); this was not observed in the placebo group (16 subjects). When cumulative pre-post differences were compared between the Aquamin and placebo groups, Aquamin treatment significantly decreased these differences (a 24% decrease as compared to a 38% increase with placebo, p = 0.0284). Subjects who received Aquamin for 90-days showed intermediary responses. Subjects receiving Aquamin for 180 days also demonstrated increases in bone mineral density (BMD) and bone mineral content (BMC), resulting in a statistically significant increase (7.3%, p = 0.0324) in the hip strength index over the treatment period. This was accompanied by increases in osteocalcin and TRAP5b and a decrease in BALP. The proteomic screen demonstrated upregulation of multiple gut barrier proteins, cell surface transporter molecules and certain proteins with anti-inflammatory potential in response to Aquamin. Aquamin treatment also led to downregulation of several proteins associated with the pro-inflammatory state.

Conclusion

The results presented here suggest that the use of a multi-mineral intervention improves disease-related biomarkers in patients with UC. These studies suggest the potential value of the mineral intervention as a low-cost, non-toxic adjuvant therapy for mild UC or for individuals with UC in remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeMineralsHumansBiomarkersMaleFemaleAdultMiddle AgedAlkaline PhosphataseLeukocyte L1 Antigen ComplexC-Reactive ProteinFecesOsteocalcin

Substanzen

BiomarkersAlkaline PhosphataseLeukocyte L1 Antigen ComplexC-Reactive ProteinMineralsOsteocalcin

Autor:innen und Institutionen

  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Department of Biostatistics, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.

ORCID-Profile: Muhammad N Aslam, Isabelle Harber

Förderung

  • NIGMS NIH HHS
  • NCATS NIH HHS
  • American Society for Investigative Pathology
  • Michigan Institute for Clinical and Health Research
  • University of Michigan Pandemic Research Recovery
  • University of Michigan discretionary funds

Zitieren

APA

Aslam, M. N., Turgeon, D. K., Appelman, H. D., Stidham, R., McClintock, S., Allen, R., Moraga, G., Harber, I., Jencks, K. J., McNeely, M. M., Sen, A., Jepsen, K. J., & Varani, J. (2025). A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial. PLOS One. https://doi.org/10.1371/journal.pone.0337408

Vancouver

Aslam MN, Turgeon DK, Appelman HD, Stidham R, McClintock S, Allen R, et al. A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial. PLOS One. 2025. doi:10.1371/journal.pone.0337408

BibTeX
@article{Aslam2025,
  author = {Aslam, Muhammad N and Turgeon, Danielle Kim and Appelman, Henry D and Stidham, Ryan and McClintock, Shannon and Allen, Ron and Moraga, Gillian and Harber, Isabelle and Jencks, Kara J and McNeely, Molly M and Sen, Ananda and Jepsen, Karl J and Varani, James},
  title = {A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0337408}
}
Kostenlos starten →